Issued Patents All Time
Showing 26–50 of 70 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 10519163 | Pyrrolopyrimidine derivatives as TAM inhibitors | Yun-Long Li, David M. Burns, Hao Feng, Joseph Glenn, Song Mei +3 more | 2019-12-31 |
| 10513493 | Cyclopropylamines as LSD1 inhibitors | Liangxing Wu, Ding-Quan Qian, Bo Shen, Wenqing Yao | 2019-12-24 |
| 10472367 | Imidazo[1,2-B][1,2,4]triazines as c-Met inhibitors | Jincong Zhuo, Wenqing Yao | 2019-11-12 |
| 10450313 | Bicyclic heterocycles as FGFR inhibitors | Liang Lu, Wenqing Yao, Fenglei Zhang | 2019-10-22 |
| 10442810 | Pyrrolotriazine compounds as TAM inhibitors | Yun-Long Li, Xiaozhao Wang | 2019-10-15 |
| 10300051 | Cyclopropylamines as LSD1 inhibitors | Liangxing Wu, Joel R. Courter, Bo Shen, Xiaozhao Wang, Wenqing Yao +1 more | 2019-05-28 |
| 10213427 | Substituted imidazopyridazines and benzimidazoles as inhibitors of FGFR3 | Wenqing Yao, Colin Zhang, Meizhong Xu, Jincong Zhuo | 2019-02-26 |
| 10174030 | Cyclopropylamines as LSD1 inhibitors | Liangxing Wu, Xiaozhao Wang, Joel R. Courter, Fenglei Zhang, Wenqing Yao | 2019-01-08 |
| 10131667 | Substituted tricyclic compounds as FGFR inhibitors | Liangxing Wu, Colin Zhang, Liang Lu, Wenqing Yao | 2018-11-20 |
| 10112950 | Substituted imidazo[1,2-a]pyrazines as LSD1 inhibitors | Liangxing Wu, Joel R. Courter, Jingwei Li, Liang Lu, Yaping Sun +4 more | 2018-10-30 |
| 10092570 | Heterocyclylamines as PI3K inhibitors | Yun-Long Li, Wenqing Yao, Andrew P. Combs, Eddy W. Yue, Song Mei +5 more | 2018-10-09 |
| 10053465 | Pyrrolopyrimidine derivatives as TAM inhibitors | Yun-Long Li, David M. Burns, Hao Feng, Joseph Glenn, Taisheng Huang +4 more | 2018-08-21 |
| 10047086 | Imidazopyridines and imidazopyrazines as LSD1 inhibitors | Liangxing Wu, Leah C. Konkol, Neil Lajkiewicz, Liang Lu, Meizhong Xu +3 more | 2018-08-14 |
| 10040790 | Bicyclic heterocycles as FGFR inhibitors | Yaping Sun, Liang Lu, Wenqing Yao, Fenglei Zhang | 2018-08-07 |
| 9988387 | Imidazo[1,2-B][1,2,4]triazines as c-Met inhibitors | Jincong Zhuo, Wenqing Yao | 2018-06-05 |
| 9981975 | Pyrrolotriazine compounds as tam inhibitors | Yun-Long Li, Xiaozhao Wang | 2018-05-29 |
| 9957229 | Amido compounds and their use as pharmaceuticals | Wenqing Yao, Jincong Zhuo, Meizhong Xu, Colin Zhang, Brian W. Metcalf +1 more | 2018-05-01 |
| 9944645 | Imidazotriazines and imidazopyrimidines as kinase inhibitors | Jincong Zhuo, Meizhong Xu, Colin Zhang, Ding-Quan Qian, David M. Burns +3 more | 2018-04-17 |
| 9944647 | Heterocyclic compounds as LSD1 inhibitors | Zhenwu Li, Liangxing Wu, Wenqing Yao, Fenglei Zhang | 2018-04-17 |
| 9745311 | Substituted pyrrolo[2,3-b]pyrazines as FGFR inhibitors | Liang Lu, Wenqing Yao | 2017-08-29 |
| 9730939 | Heterocyclylamines as PI3K inhibitors | Yun-Long Li, Wenqing Yao, Andrew P. Combs, Eddy W. Yue, Song Mei +5 more | 2017-08-15 |
| 9695180 | Substituted imidazo[1,2-a]pyrazines as LSD1 inhibitors | Liangxing Wu, Joel R. Courter, Jingwei Li, Liang Lu, Yaping Sun +4 more | 2017-07-04 |
| 9695168 | Substituted imidazo[1,5-α]pyridines and imidazo[1,5-α]pyrazines as LSD1 inhibitors | Liangxing Wu, Leah C. Konkol, Neil Lajkiewicz, Liang Lu, Meizhong Xu +3 more | 2017-07-04 |
| 9670154 | Amido compounds and their use as pharmaceuticals | Wenqing Yao, Jincong Zhuo, Meizhong Xu, Colin Zhang, Brian W. Metcalf +1 more | 2017-06-06 |
| 9670210 | Cyclopropylamines as LSD1 inhibitors | Liangxing Wu, Wenqing Yao, Fenglei Zhang | 2017-06-06 |